ELTP - Elite Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.08498
-0.00102 (-1.19%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.08600
Open0.08500
Bid0.00000 x 0
Ask0.00000 x 0
Day's Range0.08220 - 0.08700
52 Week Range0.06000 - 0.22000
Volume228,484
Avg. Volume417,811
Market Cap67.263M
Beta1.22
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Elite Pharmaceuticals, Inc. :ELTP-US: Earnings Analysis: Q4, 2017 By the Numbers : June 16, 2017
    Capital Cube11 months ago

    Elite Pharmaceuticals, Inc. :ELTP-US: Earnings Analysis: Q4, 2017 By the Numbers : June 16, 2017

    Categories: Yahoo FinanceGet free summary analysis Elite Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Elite Pharmaceuticals, Inc. – Mylan N.V., Acura Pharmaceuticals, Inc., Cambrex Corporation, Aceto Corporation, Nektar Therapeutics, Pfizer Inc. and Albany Molecular Research, Inc. (MYL-US, ACUR-US, CBM-US, ACET-US, NKTR-US, PFE-US ... Read more (Read more...)

  • We're sorry this is all we were able to find about this topic.